MCM
SPPI

Matarin Capital Management’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Matarin Capital Management’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-26,748
Closed -$176K – 258
2016
Q2 		$176K Buy
+26,748
New +$189K 0.02% 230

Other funds holding SPPI

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Matarin Capital Management's SPPI Position: Q3 2016 in Review

Matarin Capital Management sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q3 2016, closing a stake of 26,748 shares — an estimated $176K sold.

Matarin Capital Management first reported a position in SPPI in Q2 2016 and held it in 1 quarter. The position peaked at $176K in Q2 2016. 144 funds tracked by Wall St. Rank hold SPPI as of Q3 2016.

  • Matarin Capital Management reported no remaining Spectrum Pharmaceuticals Inc position as of Q3 2016 after selling out during the quarter.
  • Matarin Capital Management sold 26,748 Spectrum Pharmaceuticals Inc shares in Q3 2016, an estimated $176K.
  • Matarin Capital Management first reported a position in Spectrum Pharmaceuticals Inc in Q2 2016 and held it in 1 quarter.
  • Matarin Capital Management's Spectrum Pharmaceuticals Inc position peaked at $176K in Q2 2016.
  • 144 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q3 2016.

Based on Matarin Capital Management's 13F filing for Q3 2016, filed 9 Nov 2016.